What is Ultragenyx Pharmaceutical's treasury stock?

Ultragenyx Pharmaceutical (RARE) reported treasury stock of $10M in Q1 2026.

How has Ultragenyx Pharmaceutical's treasury stock changed year-over-year?

Ultragenyx Pharmaceutical's treasury stock increased by 32.2% year-over-year, from $7.57M to $10M.

What does treasury stock mean?

Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

Ultragenyx Pharmaceutical RARE Treasury Stock

Treasury Stock at other companies

Arrowhead ResearchARWR

$53.19M—

CRISPR TherapeuticsCRSP

$60K-3.2%

BridgeBio PharmaBBIO

$405.78M+25.5%

ANI PharmaceuticalsANIP

$53M+70.7%

TG TherapeuticsTGTX

$200.23M+1,225%

Other financials

Income statement

See full

Revenue$136.0M-2.2%

Operating income-$169.0M-18.2%

Net income-$185.0M-22.5%

EPS (diluted)-$1.84-17.2%

Balance sheet

See full

Cash & equivalents$175.0M+37.8%

Total debt$36.0M-10.8%

Total equity-$236.0M-264%

Total assets$1.3B-1.2%

Cash flow

See full

Operating cash flow-$197.0M-18.7%

CapEx$1.0M0.0%

Free cash flow-$198.0M-18.6%

Valuation

See full

Market cap$2.83B-39.4%

P/S4.2×-3.7×

Profitability

See full

Gross margin97.2%—

Operating margin-83.8%-3.0pp

Net margin-90.9%-2.1pp

FCF margin-75.1%+10.7pp

Returns & leverage

See full

Return on equity-325.6%+36.9pp

Debt / equity3.7×—

Current ratio2×-0.4×

Where this comes from

Reported directly by Ultragenyx Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's treasury stock?: Ultragenyx Pharmaceutical (RARE) reported treasury stock of $10M in Q1 2026.
How has Ultragenyx Pharmaceutical's treasury stock changed year-over-year?: Ultragenyx Pharmaceutical's treasury stock increased by 32.2% year-over-year, from $7.57M to $10M.
What does treasury stock mean?: Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.